These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14440189)

  • 21. [Therapy of malignant lymphomas].
    Farreras Valentí P
    Prog Ter Clin; 1965 Jul; 18(4):829-63. PubMed ID: 5321624
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of malignant nonHodgkin's lymphomas].
    Stolzenbach G
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1778-81. PubMed ID: 923461
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Klastersky J
    Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
    [No Abstract]   [Full Text] [Related]  

  • 24. [Malignant lymphomas].
    Hiddemann W
    Internist (Berl); 2016 Mar; 57(3):205. PubMed ID: 26842682
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term therapy in leukemias and malignant lymphomas].
    Aul C; Schneider W
    Fortschr Med; 1983 Feb; 101(7):275-82. PubMed ID: 6840654
    [No Abstract]   [Full Text] [Related]  

  • 26. [Internal medicine therapy of malignant lymphomas].
    Sauter C
    Ergeb Inn Med Kinderheilkd; 1976; 38():1-35. PubMed ID: 782876
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current possibilities and trends in the treatment of malignant lymphomas].
    Kálmán R
    Orv Hetil; 1978 Sep; 119(38):2299-309. PubMed ID: 693034
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term side effects of the treatment of malignant lymphomas (author's transl)].
    Joss R; Brunner K; Greiner R
    Ther Umsch; 1981 Sep; 38(9):912-9. PubMed ID: 7292373
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of uracil mustard in chronic lymphatic leukemia and malignant lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    Cancer Chemother Rep; 1961 Apr; 11():77-80. PubMed ID: 13752495
    [No Abstract]   [Full Text] [Related]  

  • 30. Secondary neoplasms in malignant lymphomas after intensive therapy.
    Bonadonna G; De Lena M; Banfi A; Lattuada A
    N Engl J Med; 1973 Jun; 288(23):1242-3. PubMed ID: 4512612
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intensive chemotherapy and bone marrow autograft in malignant lymphomas (author's transl)].
    Stryckmans P; Debusscher L; Delforge A; Bron D; Vanhaelen C; Ronge-Collard E; Bieva C; Loos M
    Rev Med Brux; 1982 Apr; 3(4):255-60. PubMed ID: 7046009
    [No Abstract]   [Full Text] [Related]  

  • 32. [Value and action of cytostatics in malignant lymphatic system diseases].
    FLEISCHHACKER H; STACHER A
    Wien Z Inn Med; 1962 May; 43():200-8. PubMed ID: 13893500
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous lymphomas.
    Klemke CD
    J Dtsch Dermatol Ges; 2014 Jan; 12(1):7-28; quiz 29-30. PubMed ID: 24393310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Cyren-B as a leukocyte protecting agent in patients undergoing radiotherapy or chemotherapy for malignant lymphoma.
    WEBSTER JH; LESSMANN EM; SOKAL JE
    Acta radiol; 1961 Sep; 56():231-6. PubMed ID: 14040199
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of the non-Hodgkin's lymphomas.
    Canellos GP
    Med Times; 1978 Mar; 106(3):37-41. PubMed ID: 345038
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-Hodgkin's malignant lymphomas: treatment of localized relapses with chemo + radio + BCG-therapy.
    Hoerni B; Eghbali H; Hoerni-Simon G; Durand M
    Oncology; 1982; 39(5):292-4. PubMed ID: 7048172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current chemotherapeutic trends in the treatment of malignant lymphomas with special reference to Hodgkin's disease].
    Novi C
    Minerva Med; 1975 Feb; 66(8):391-8. PubMed ID: 1089921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the use of high doses of cytostatic target therapy and autologous bone marrow transplantation in malignant lymphoreticulum diseases].
    PESCHL L; REIMER EE; SIMON W
    Krebsarzt; 1962 Apr; 17():147-54. PubMed ID: 14485656
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of non-Hodgkin's lymphomas (author's transl)].
    Kenis Y; Vanderlinden B; Bron D
    Rev Med Brux; 1982 Apr; 3(4):243-8. PubMed ID: 7046008
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analysis and therapy of recurrences of nonHodgkin lymphomas].
    Sciascia R; Babini L; Barbieri E; Emiliani E; Fiacchini M; Lauria F
    G Clin Med; 1977; 58(7-8):249-56. PubMed ID: 924047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.